Glucose Health, Inc. USPTO Patent Filing Asserts First Use of Nutritional Composition Underlying GLUCODOWN®
Glucose Health, Inc. USPTO Patent Filing Asserts First Use of Nutritional Composition Underlying GLUCODOWN®
BENTONVILLE, AR, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC Pink: GLUC) ("Company") is pleased to advise that a patent application for "Compositions and Methods for Metabolic Health" was filed with the United States Trademark and Patent Office (USPTO) on December 23, 2021, on behalf of the Company.
阿肯色州本頓維爾，2021年12月28日(Global Newswire)--葡萄糖健康公司(OTC Pink：GLUC)) (“公司”)很高興地通知您，代表公司於2021年12月23日向美國商標和專利局(USPTO)提交了“新陳代謝健康成分和方法”的專利申請。
The patent filing discloses a composition of the combination of resistant dextrin, corosolic acid and chromium picolinate, in measures for maintaining and improving health by attenuating post-prandial glycemic and lipid increases and/or lowering levels of plasma glucose and lipids. The composition disclosed is the nutritional foundation of the Company's GLUCODOWN® products.
專利申請公開了一種抗藥性糊精、珊瑚酸和吡啶甲酸鉻的組合物，用於通過減輕餐後血糖和血脂升高和/或降低血糖和血脂水平來維持和改善健康。所披露的組合物是該公司GLUCODOWN®產品的營養基礎。
The purpose of the USPTO filing is to assert Glucose Health, Inc.'s claims and rights for the way in which the composition may be used. Prior to filing, a worldwide patent search was commissioned, which indicated the composition disclosed by the Company is its first use, in the context of a nutritional product, in the world.
美國專利商標局提交申請的目的是維護葡萄糖健康公司對該組合物使用方式的權利和權利。在提交申請之前，該公司委託進行了一次全球專利搜索，這表明該公司披露的組合物是它在世界上第一次在營養產品中使用。
About Glucose Health, Inc. (OTC Pink: GLUC)
葡萄糖健康公司(OTC)簡介 粉色：GLUC)
With its focus on creating delicious beverages nutritionally appropriate1 for the nation's 100+ million2 pre and Type-2 diabetics, Glucose Health, Inc., the manufacturer of GLUCODOWN®, is uniquely positioned among emerging beverage companies. Introduced in the third quarter of 2018, the Company's GLUCODOWN® is the market leading brand for new & innovative, diabetic friendly & delicious, beverages. Glucose Health, Inc. is a publicly traded company with the ticker symbol OTC Pink: GLUC.
GLUCODOWN®的製造商GLUCODOWN®的製造商葡萄糖健康公司專注於為全國1億多名2型糖尿病患者創造營養適中的美味飲料1，在新興飲料公司中處於獨特的地位。該公司於2018年第三季度推出的GLUCODOWN®是市場領先的新型創新、對糖尿病友好的美味飲料品牌。葡萄糖健康公司是一家上市公司，股票代碼為OTC Pink：GLUC。
To buy GLUCODOWN® visit our Amazon Store at:
要購買GLUCODOWN®，請訪問我們的亞馬遜商店：
Like us on Facebook at:
在Facebook上點讚我們：
For more GLUC information, visit:
有關GLUC的更多信息，請訪問：
1 For citations visit
1用於引用訪問
2 National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services
2 2020年全國糖尿病統計評論衞生與公眾服務部疾病控制和預防中心
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and while Glucose Health, Inc. is not subject to the 1934 Securities and Exchange Act, contains forward-looking statements within the meaning Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential, "possible," "probable, "believes," "seeks," "may, "will, "should," "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.
本新聞稿包含符合1933年“證券法”(經修訂)第27A條的前瞻性陳述，雖然葡萄糖健康公司不受1934年“證券交易法”的約束，但含有符合1934年“證券交易法”第21E條(經修訂)的前瞻性陳述。不描述歷史事實的陳述構成前瞻性陳述，經常但並非總是通過使用“預期”、“預期”、“打算”、“估計”、“計劃”、“可能”、“相信”、“尋求”、“可能”、“將會”、“應該”、“可能”或此類術語的否定或其他類似表述來識別。由於公司業務固有的風險和不確定性，實際結果可能與本新聞稿中陳述的大不相同。告誡讀者不要過度依賴這些前瞻性陳述，這些陳述僅説明截至本文發佈之日的情況。所有前瞻性陳述都完全受本警告性聲明的限制，公司沒有義務修改或更新本新聞稿，以反映此後發生的事件或情況。
Contact:
聯繫方式：
Murray Fleming
默裏·弗萊明
Glucose Health, Inc.
葡萄糖健康公司
info@glucosehealthinc.com
電子郵箱：info@graoseHealth Thinc.com
(479) 802-3827
(479) 802-3827
譯文內容由第三人軟體翻譯。